Ubiquiti has released security updates to patch three maximum severity vulnerabilities in UniFi OS that can be exploited by remote attackers without privileges. UniFi OS is a unified operating system ...

Wear OS 7 has been announced, set to release to supported smartwatches later this year. Google claims that watches upgrading from Wear OS 6 to Wear OS 7 can expect up to 10% improvement in battery ...

Highlights of Python 3.15, now available in beta, include lazy imports, faster JITs, better error messages, and smarter profiling. The first full beta of Python 3.15 ...

Zorin released Zorin OS 18.1 recently, but I’ve been using a near-final version since the previous week. This is clearly one of the best Linux distributions for Windows switchers looking for a soft ...

Your attack surface no longer lives on one operating system, and neither do the campaigns targeting it. In enterprise environments, attackers move across Windows endpoints, executive MacBooks, Linux ...

No more waiting on slow-loading modules or wasting time on ad hoc workarounds: Python 3.15’s new ‘lazy imports’ mechanism has you covered. When you import a module in Python, the module’s code must be ...

In the age of artificial intelligence, researchers at Cornell University have created an online module aimed at helping students build one of higher education’s most enduring—and often ...

This is read by an automated voice. Please report any issues or inconsistencies here. “In that darkness, I found myself,” says Mexican pop star Kenia Os, who collaborated with indie icon Carla ...

is the Verge’s weekend editor. He has over 18 years of experience, including 10 years as managing editor at Engadget. Of course, part of the appeal is also the cyberpunk good looks that draw obvious ...

Xiaomi used an internal awards event to highlight its record innovations. The company further outlines its plans to unify its self-developed chip, OS, and AI by 2026 through massive long-term ...

Findings showed datopotamab deruxtecan significantly improved PFS and OS vs chemotherapy. Topline data were announced from a phase 3 trial evaluating datopotamab deruxtecan-dlnk as a first-line ...